Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019)

The University of Texas System (UT)

Status

Conditions: Gastrointestinal Stromal Tumor

Treatments: Drug: Everolimus

Study type: Expanded Access

Funder types: Other

Identifiers

NCT03493152

CTMS# 18-0019

HSC20180169T (Other Identifier)

Details and patient eligibility

About

Single patient treatment with everolimus.

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria